149 related articles for article (PubMed ID: 35079925)
1. To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.
Compaoré ZC; Monnet E; Gérazime A; Molinié F; Guizard AV; Delafosse P; Dabakuyo-Yonli TS; Coureau G; Hammas K; Plouvier S; Bara S; Défossez G; Lapôtre-Ledoux B; Daubisse-Marliac L; d'Almeida T; Launoy G; Mansi L; Trétarre B; Woronoff AS
Cancer Causes Control; 2022 Mar; 33(3):403-415. PubMed ID: 35079925
[TBL] [Abstract][Full Text] [Related]
2. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
3. About invasive cervical cancer: a French population based study between 1998 and 2010.
Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
[TBL] [Abstract][Full Text] [Related]
4. Special Focus on Stage IV Cervical Cancer Patients: A Decade Experience.
Espenel S; Garcia MA; Langrand-Escure J; Vallard A; Trone JC; Rancoule C; Vial N; Moreno-Acosta P; Chauleur C; Boutet C; Peoc Apos H M; Prevot-Bitot N; Guy JB; Magné N
Oncology; 2019; 97(3):125-134. PubMed ID: 31266037
[TBL] [Abstract][Full Text] [Related]
5. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
[TBL] [Abstract][Full Text] [Related]
6. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
[TBL] [Abstract][Full Text] [Related]
7. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
[TBL] [Abstract][Full Text] [Related]
8. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer in older women: Does age matter?
Barben J; Kamga AM; Dabakuyo-Yonli TS; Hacquin A; Putot A; Manckoundia P; Bengrine-Lefevre L; Quipourt V
Maturitas; 2022 Apr; 158():40-46. PubMed ID: 35241237
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of histological type and staging of cervical cancer as prognostic factors among women treated in the Department of Gynecology and Oncology, Jagiellonian University in the years 2001-2014].
Basta T; Gawron I; Mirocki K; Babczyk D; Jach R
Przegl Lek; 2017; 74(1):13-20. PubMed ID: 29693995
[TBL] [Abstract][Full Text] [Related]
11. Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
Mwaliko E; Itsura P; Keter A; De Bacquer D; Buziba N; Bastiaens H; Jackie A; Obala A; Naanyu V; Gichangi P; Temmerman M
BMC Cancer; 2023 Nov; 23(1):1104. PubMed ID: 37957644
[TBL] [Abstract][Full Text] [Related]
12. [Trend in proportion and clinicopathological characteristics of young women with stage Ⅰa2 to Ⅱa2 cervical cancer].
Wang W; Hao M; Chen CL; Liu P; Ling B; Kang S; Lu AW; Wang WL; Zhao WD; Zhu QY; Zhao YY; Zhao HW; Jin SL; Ni Y; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):666-672. PubMed ID: 31648442
[No Abstract] [Full Text] [Related]
13. Epidemiology of cervical cancer in elderly women: Analysis of incidence, treatment, and survival using German registry data.
Neumeyer S; Tanaka LF; Liang LA; Klug SJ
Cancer Med; 2023 Aug; 12(16):17284-17295. PubMed ID: 37403686
[TBL] [Abstract][Full Text] [Related]
14. Uterine cervix cancer treatment at Radiumhemmet: 90 years' experience. Time trends of age, stage, and histopathology distribution.
Hellman K; Hellström AC; Pettersson BF
Cancer Med; 2014 Apr; 3(2):284-92. PubMed ID: 24421278
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
Glasmeyer L; Mcharo RD; Torres L; Lennemann T; Danstan E; Mwinuka N; Judick M; Mueller W; Mbuya W; Hölscher M; Lellé R; Geldmacher C; Kroidl A; France JR
BMC Cancer; 2022 Aug; 22(1):892. PubMed ID: 35971100
[TBL] [Abstract][Full Text] [Related]
16. Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?
Caires IQ; Souza KT; Negrão MV; de Oliveira JA; Barroso-Sousa R; de Lima RC; Hoff PM; Diz Mdel P
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():86-9. PubMed ID: 26182837
[TBL] [Abstract][Full Text] [Related]
17. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
18. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
Kim SI; Cho JH; Seol A; Kim YI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
Gynecol Oncol; 2019 Apr; 153(1):3-12. PubMed ID: 30642625
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
20. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
Matsuo K; Nusbaum DJ; Machida H; Huang Y; Khetan V; Matsuzaki S; Klar M; Grubbs BH; Roman LD; Wright JD
Am J Obstet Gynecol; 2020 May; 222(5):484.e1-484.e15. PubMed ID: 31678092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
